iposoluble vitamins in patients receiving longterm treatment with octreotide.
Recruiting
- Conditions
- Vetoplosbare vitamine deficientie, carcinoid tumor, acromegalieLiposoluble vitamin deficiency, carcinoid tumour, acromegaly
- Registration Number
- NL-OMON24514
- Lead Sponsor
- prof. dr. EGE de VriesUniversitair Medisch Centrum Groningen9700 RB Groningenthe Netherlands
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 80
Inclusion Criteria
Patients are eligible when they have used octreotide for at least 18 months. Patients must be 18 years or older and must be willing to give written informed consent.
Exclusion Criteria
No informed consent, age less then 18 years.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Liposoluble vitamins;<br /><br>2. Relevant lipid components;<br /><br>3. Relevant biochemical investigations to measure effects of possible vitamin deficiency, including calcium levels, PTH and coagulation.
- Secondary Outcome Measures
Name Time Method